期刊文献+

基质金属蛋白酶与实验性自身免疫性脑脊髓炎的免疫屏障 被引量:2

Matrix metalloproteinases and the immunological barrier of experimental autoimmune encephalomyelitis
原文传递
导出
摘要 实验性自身免疫性脑脊髓炎(experimental autoimmune cncephalomyelitis,EAE)是一种主要由T细胞介导的,以中枢神经系统(CNSl内小血管周围单个核细胞浸润及白质髓鞘脱失为特征的自身免疫性疾病。EAE炎性脱髓鞘的过程有许多重要的炎性细胞因子参与。基质金属蛋白酶(matrix metalloproteinase,MMPs)尤其是MMP-9、MMP-2是引起血脑屏障(blood brain barrier,BBB)的免疫屏障破坏,炎性细胞浸润以及介导细胞外基质(ECM)和髓磷脂降解的重要因素。
作者 魏慧星 吴钢
出处 《中华神经医学杂志》 CAS CSCD 2007年第11期1183-1185,共3页 Chinese Journal of Neuromedicine
关键词 实验性自身免疫性脑脊髓炎 基质金属蛋白酶-9 基质金属蛋白酶-2 免疫 屏障 炎性因子 Experimental autoimmtme encephalomyelitis MMP-9 MMP-2 Immunological barrier Inflammatory factors
  • 相关文献

参考文献16

  • 1Franzen B, Duvefelt K, Jonsson C, et al. Gene and protein expression profiling of human cerebral endothelial cells activated with tumor necrosis factor-alpha [J]. Brain Res Mol Brain Res, 2003, 115(2): 130-146.
  • 2Hart MN, Fabry Z. CNS antigen presentation [J]. Trends Neurosci, 1995, 18(11): 475-481.
  • 3Bechmann I, Mor G, Nilsen J, et al. FasL (CD95L, ApolL) is expressed in the normal rat and human brain: evidence for the existence of an immunological brain barrier[J]. Glia, 1999, 27(1): 62-74.
  • 4Balabanov R, Beaumont T, Dore-Duffy P. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes[J]. J Neurosci Res, 1999, 55(5): 578-587.
  • 5Brown RC, Mark KS, Egleton RD, et al. Protection against hypoxia-induced increase in blood-brain barrier permeability: role of tight junction proteins and NFB [J]. J Cell Sci, 2003, 116(4): 693.
  • 6Gloor SM, Wachtel M, Bolliger MF, et al. Molecular and cellular permeability control at the blood-brain barrier [J]. Brain Res Rev, 2001, 36(2-3): 258-264.
  • 7Brundula V, Rewcastle NB, Metz LM, et al. Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis[J]. Brain, 2002, 125(Pt 6): 1297-1308.
  • 8Lohmann C, Krischke M, Wegener J, et al. Tyrosine phosphatase inhibition induces loss of blood-brain barrier integrity by matrix metalloproteinase-dependent and -independent pathways [J]. Brain Res, 2004, 995(2): 184-196.
  • 9Schmidt J, Sturzebecher S, Toyka KV, et al. Interferon-beta treatment of experimental autoimmune encephalomyelitis leads to rapid nonapoptotic termination of T cell infiltration [J]. J Neurosci Res, 2001, 65(1): 59-67.
  • 10Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases evolution, structure and function [J]. Biochim Biophys Acta, 2000, 1477(1-2): 267-283.

二级参考文献9

  • 1Dunsmore S,Rubin J,Kovacs S,et al.Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinaseproduction[J]. J Biol Chem, 1996,271:24576-24582.
  • 2Gijbels K,Galardy R,Steinman L. Reversal of autoimmune encephalomyelitis with ahydroxamate inhibitor of matrix metalloproteases[J]. J Clin Invest, 1994,94:2177-2182.
  • 3Hewson A,Smith T,Leonard J, et al. Suppression of experimental allergicencephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790[J].Inflamm Res, 1995,44:345-349.
  • 4Clements J,Cossins J,Wells G, et al. Matrix metalloproteinase expression duringexperimental autoimmune encephalomyelitis and effects of a combined matrixmetalloproteinase and tumour necrosis factor-α inhibitor[J]. J Neuroimmunol,1997,74:85-94.
  • 5Chandler S,Cossins J,Lury J,et al. Macrophage metalloelastase degrades matrix andmyelin proteins and processes a tumour necrosis factor-alpha fusion protein[J]. BiochemBiophys Res Commun, 1996,228:421-429.
  • 6Gearing A,Beckett P,Christodoulou M,et al. Processing of tumor necrosis factor-αprecursor by metalloproteinases[J]. Nature, 1994,370:555-557.
  • 7Rosenberg G,Dencoff J,Correa N,et al. Effect of steroids on CSF matrixmetalloproteinases in multiple sclerosis: relation to blood-brain barrier injury[J].Neurology, 1996,46:1626-1632.
  • 8Hilliard BA,Mason N,Xu L,et al. Critical roles of c-Rel in autoimmune inflammationand helper T cell differentiation[J]. J Clin Invest, 2002,110:843-850.
  • 9Yang J,Lindsberg PJ,Hukkanen V,et al. Differential expression of cytokines andadhesion molecule between spleen and lymph nodes associates with remission in chronicrelapsing experimental autoimmune encephalomyelitis[J]. Scand J Immunol, 2002,56:286-293.

共引文献2

同被引文献17

  • 1巫顺秀,陈显光,李森美,杜登青,王文莉.脑脊液γ-干扰素检测对结核性脑膜炎诊断价值的探讨[J].华中医学杂志,2006,30(1):41-42. 被引量:14
  • 2王心静,王巍,叶一秀,王卫,孟祥红.结核性脑膜炎患者脑脊液基质金属蛋白酶-9及其抑制剂检测[J].实用医学杂志,2007,23(16):2485-2486. 被引量:10
  • 3Misraa UK, Kalitaa J, Srivastava R, et al. A study of cytokines in tuberculous meningitis: clinical and MRI correlation [J]. Neurosci Lett, 2010, 483(1): 6-10.
  • 4Yilmaz E, Gtirgoze MK, Ilhan N, et al. Interleukin-8 levels in children with bacterial, tuberculous and aseptic meningitis [J]. Indian J Pediatr, 2002, 69(3): 219-221.
  • 5Lee KY, Kim EH, Yang WS, et al. Persistent increase of matrix metalloproteinases in cerebrospinal fluid of tuberculous meningitis [J]. J Neurol Sci, 2004, 220(1-2): 73-78.
  • 6Farrar MA, Sehreiber RD. The molecular cell biology of interferon-gamma and its receptor[J]. Annu Rev Immunol, 1993, 11: 571-611.
  • 7Besbas N, Ozahin F, Catal F, et al. Monocyte chemoattractant protein-1 and interleukin-8 levels in children with acute poststreptococcaI glomerulonephritis[J]. Pediatr Nephrol, 2004, 19 (8): 864-868.
  • 8Chen KM, Liu JY, Lai SC, et al. Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis [J]. Int J Exp Pathol, 2006, 87(2): 113-119.
  • 9Price NM , Farrar J, Trail TT, et al. Identification of a matrix-degrading phenotype in human tuberculosis in vitro and invivo[J]. J Immunol, 2001, 166(6): 4223-4230.
  • 10Juan RS, Sanchez-Suarez C, Rebollo MJ, et al. Interferon gamma quantification in cerebrospinal fluid compared with PCR for the diagnosis of tuberculous meningitis [J]. J Neurol, 2006, 253 (10): 1323-1330.

引证文献2

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部